Primary Immunodeficiency disorders (PID) have been increasingly recognized in
association with hematologic malignancies. To better appreciate this association, a systemic …

Many primary immunodeficiency disorders (PIDD) are associated with elevated risks for
different types of cancer. Defective immunosurveillance mechanisms in PIDD and infection …

Primary immunodeficiencies (PIDs) are a heterogeneous group of inherited disorders
characterized by aberrant immune function that leads to increased susceptibility to infections …

Background: Immunodeficiencies (ID), in particular primary immunodeficiencies (PID), are
often associated with haematological manifestations, such as peripheral cytopenias or …

Primary immunodeficiencies (PIDs), a heterogenous group of inborn errors of immunity, are
predetermined at birth but may evolve with age, leading to a variable clinical and laboratory …

Primary immunodeficiency disorders (PIDs) convey increased susceptibility to infections and
sometimes to malignancies, particularly lymphomas. Such cancer development can be …

Malignancies occur with a higher incidence rate and manifest earlier in life in patients with
primary immunodeficiency disorders (PIDs) than in the general population. However, no …

Primary immunodeficiency disorders (PID) are a group of heterogeneous disorders
characterized by recurrent infections, autoimmunity, increased lymphoproliferative disorders …

In the past, primary immunodeficiency disorders (PIDs) have been described as diseases
caused by 1 or more defects of the immune system, leading to increased susceptibility to …

Purpose Patients with primary immunodeficiency diseases (PIDD) may present with
recurrent infections affecting different organs, organ-specific inflammation/autoimmunity, and …